Long-term agalsidase beta therapy is associated with improvements in pain and quality of life among patients with Fabry disease

被引：0
|
作者：
Guffon, N.
Germain, D. P.
Waldek, S.
Banikazemi, M.
Bushinsky, D. A.
Charrow, J.
Lee, P.
Loew, T.
Vedder, A. C.
Wilcox, W. R.
机构：
[1] Hop Edouard Herriot, Lyon, France
[2] Hop Europeen Georges Pompidou, Paris, France
[3] Hope Hosp, Manchester, Lancs, England
[4] Mt Sinai Sch Med, New York, NY USA
[5] Univ Rochester, Sch Med, Rochester, NY 14627 USA
[6] Childrens Mem Hosp, Chicago, IL 60614 USA
[7] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[8] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[9] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[10] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
CLINICAL THERAPEUTICS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0149-2918(07)80154-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] Long-term outcomes in patients with Fabry disease who were treated with agalsidase alfa for more than nineteen years: The Fabry Outcome Survey
    Giugliani, Roberto
    Hughes, Derralynn
    Nicholls, Kathy
    Niu, Dau-Ming
    Reisin, Ricardo C.
    Botha, Jaco
    Anagnostopoulou, Christina
    West, Michael L.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 49 - 50
  • [32] Quality of life of patients undergoing long-term oxygen therapy
    Wroblewska, Izabela
    Turek, Renata
    Sochocka, Lucyna
    Steciwko, Andrzej
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2011, 13 (03): : 542 - 546
  • [33] Unexpected Hypotension in a Female Patient with Fabry Disease: Switching from Agalsidase α to β after Long-term ERT
    Sugiura, Takuya
    Muto, Reiko
    Amano, Tatsuaki
    Kamiya, Fumitaka
    Sato, Yuka
    Maeda, Kayaho
    Saito, Shoji
    Katsuno, Takayuki
    Kato, Noritoshi
    Higashi, Michiko
    Numaguchi, Atsushi
    Matsuda, Naoyuki
    Sugiura, Kazumitsu
    Maruyama, Shoichi
    INTERNAL MEDICINE, 2025,
  • [34] Long-term outcomes and quality of life in patients with Hirschsprung disease
    Pakarinen, Mikko P.
    Mutanen, Annika
    WORLD JOURNAL OF PEDIATRIC SURGERY, 2024, 7 (03)
  • [35] NEUROLOGIC ASSESSMENT IN PATIENTS WITH FABRY DISEASE BEFORE AND AFTER ENZYME REPLACEMENT THERAPY (ERT) WITH AGALSIDASE BETA
    Mendes, C. S. C.
    Rand, M. H.
    Kyosen, S. O.
    Martins, A. M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S157 - S157
  • [36] Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance
    Nachman, Fabio
    Planzer del Campo, Marcela
    Gonzalez, Andrea
    Corzo, Laura
    Vazquez, Horacio
    Sfoggia, Cristina
    Smecuol, Edgardo
    Pinto Sanchez, Maria Ines
    Niveloni, Sonia
    Sugai, Emilia
    Maurino, Eduardo
    Bai, Julio C.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (10) : 685 - 691
  • [37] A MULTICENTER STUDY OF LONG-TERM ENZYME REPLACEMENT THERAPY IN PATIENTS WITH FABRY DISEASE IN GREECE
    Andrikos, A.
    Iatrou, Ch.
    Boletis, J. N.
    Diamandopoulos, A.
    Pappas, M.
    Kalaitzidis, K.
    Katsinas, Ch.
    Balafa, O.
    Revela, I.
    Dimitroula, V.
    Drakoulogona, O.
    Ouzouni, A.
    Siamopoulos, K. C.
    CLINICAL THERAPEUTICS, 2009, 31 : S39 - S39
  • [38] Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia
    Kathryn E. Flynn
    Ehab Atallah
    Current Hematologic Malignancy Reports, 2016, 11 : 80 - 85
  • [39] Influence of long-term therapy of RLS on patients' quality of life.
    Sieminski, M.
    Chelminiak, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 271 - 271
  • [40] Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia
    Flynn, Kathryn E.
    Atallah, Ehab
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (02) : 80 - 85
12345